About
About MetaResearch
MetaResearch reads published studies on metabolic health, longevity and peptide science, then sets out what each one measured, how strong the evidence behind it is, and which questions it leaves open.

MetaResearch is an independent publication about research itself. It reads studies on metabolic health, longevity and peptide science, and reports three things about each one: what the researchers actually measured, how much weight the result can carry, and what is still unknown.
Every briefing starts from the primary record, meaning the published paper, the trial registry entry or the approved label, rather than from a press summary. Figures are quoted as the investigators reported them, with the source numbered in the text. Where studies disagree, both results appear. Where a finding comes from animals, from a small group of patients or from an analysis added after a trial ended, the briefing says so in the same breath as the number.
MetaResearch is published by MRG Canada. It reports research and gives no medical advice, recommends or supplies nothing, and has no clinical practice behind it. Readers with a health question are directed to their own clinician.
What it covers
- Metabolic. Studies of blood sugar, body weight, appetite hormones and the medicines built around them.
- Longevity. Work on biological aging, the tests that try to measure it, and how far those tests can be trusted.
- Advanced Biologics. Peptides and other engineered biologic molecules, including antibodies, fusion proteins and engineered enzymes: how they are made, how they are tested, and where the human evidence stands.
- Trials explained. How clinical trials are designed, counted and reported, and what separates a settled result from an early one.
- Reference. Plain definitions of the research terms used across these briefings, each one tied to a source.
Independence
MetaResearch is an independent publication and is not affiliated with Meta Platforms, Inc.
MetaResearch is paid for by display advertising on the site and by offers from partners in its email briefings. Both are labelled where they appear, and every partner message names the partner. Advertisers and partners have no say in which studies are covered, what a briefing concludes, or how a finding is described, and no advertiser sees a briefing before it is published. Where an offer relates to a subject MetaResearch also reports on, the reporting is written from the primary sources exactly as it would have been with no offer attached.
Research reporting only. Nothing on this site is medical advice, a diagnosis, or a recommendation to take, stop or change any medicine.
How this publication works
Who publishes it
Editorial standardsHow it is funded
How MetaResearch makes moneyHow corrections work
ContactNewsletter
The MetaResearch briefing
A short email when a study worth reading is published, with the finding, its limits and the link to the source.